Callan JMB

11/03/2026

A new chapter in pharmaceutical manufacturing is taking shape.

Imagine medication delivered through a thin strip that dissolves quickly, without the need for water or traditional tablets.

That’s the innovation behind Rapid Dose Therapeutics’ QuickStrip™ technology, and it’s now part of Callan JMB’s expanding U.S. manufacturing strategy.

With the production equipment delivered to our Texas facility, we're moving toward a new manufacturing capability with potential applications across pharmaceuticals, wellness, and emergency healthcare preparedness.

And the business opportunity is significant: up to $15 million in projected revenue during the first 18 months of operation**, following successful equipment qualification.

This milestone is about more than introducing a new technology. It’s about creating additional revenue opportunities, strengthening domestic pharmaceutical production, and expanding the capabilities of our healthcare platform.

The next chapter of Callan JMB is taking shape.

Read the full announcement: https://www.globenewswire.com/news-release/2026/11/02/3393064/0/en/

11/02/2026

Big news for Callan JMB! A new chapter in American pharmaceutical manufacturing is taking shape.

We've officially received Rapid Dose Therapeutics’ QuickStrip™ oral thin-film production line at our Texas facility, opening the door to a new manufacturing capability with up to $15 million in projected revenue over its first 18 months of operation, following successful qualification.

QuickStrip™ uses innovative, fast-dissolving technology to deliver active ingredients without water or traditional tablets, offering exciting possibilities across healthcare, pharmaceutical manufacturing and emergency preparedness.

This milestone builds on our continued investment in domestic pharmaceutical capabilities and follows our recent announcement of the IV bag manufacturing facility at the Atlas Complex in Alabama.

Two major manufacturing initiatives. New opportunities for revenue growth. One clear vision: strengthening America's healthcare supply chain.

Both projects are moving forward without requiring additional capital raises.

We're building for the future of American healthcare.

Read the full announcement: https://www.globenewswire.com/news-release/2026/11/02/3393064/0/en/callan-jmb-announces-arrival-of-rapid-dose-therapeutics-quickstrip-resulting-in-15-million-in-projected-revenue-over-the-next-18-months.html

10/30/2026

Big things are taking shape in Marion, Alabama! 🇺🇸

Callan JMB is moving closer to breaking ground on a new $16 million IV bag manufacturing facility at the Atlas Complex, marking another major step toward bringing critical pharmaceutical production back to American soil.

And there's even more to this milestone.

The facility is 100% funded through a third-party partnership, without diluting existing shareholders or adding interest-bearing debt.

Once fully operational, the facility is projected to generate $450 million in annual revenue, while supporting a stronger, more reliable U.S. healthcare supply chain.

With blueprints approved and groundbreaking expected before the end of October, this is an exciting new chapter for the Atlas Complex, Callan JMB, and the future of American pharmaceutical manufacturing.

We're building more than a facility. We're helping build a stronger foundation for America's healthcare preparedness.

Read the full announcement:
https://www.globenewswire.com/news-release/2026/10/22/3386273/0/en/callan-jmb-to-break-ground-on-iv-bag-manufacturing-facility-fully-funded-by-non-dilutive-and-non-interest-bearing-third-party-partnership.html

10/28/2026

Preparedness isn’t about knowing when the next crisis will happen. It’s about having the infrastructure, resources, and systems in place to respond effectively when it does.

That’s the approach behind Callan JMB’s commitment to emergency preparedness and response.

Learn more: https://callanjmb.com/emergency-preparedness-and-response

10/22/2026

A Major Step Forward for American Pharmaceutical Manufacturing!

Callan JMB is preparing to break ground on a new $16 million IV bag manufacturing and distribution facility at the Atlas Complex by CJMB in Marion, Alabama, before the end of October!

Even more significantly, the entire facility will be funded through a non-dilutive, non-interest-bearing third-party partnership**, allowing the project to advance without adding debt to the company's balance sheet or diluting existing shareholders.

Once fully operational, the facility is projected to generate $450 million in annual revenue through the production of standard IV bags and premixed drug IV bags.

The planned facility will bring together automated manufacturing, quality control, and advanced distribution capabilities, supporting a more reliable domestic supply of essential medical products.

As part of our broader Atlas Complex initiative and collaboration with Alabama State University, this project reflects our commitment to creating opportunities, expanding American manufacturing, and strengthening the nation's healthcare preparedness.

The blueprints are approved. Groundbreaking is next. The future of domestic pharmaceutical manufacturing is taking shape.

Learn more: www.globenewswire.com/news-release/2026/10/22/3386273/0/en/callan-jmb-to-break-ground-on-iv-bag-manufacturing-facility-fully-funded-by-non-dilutive-and-non-interest-bearing-third-party-partnership.html

10/20/2026

Callan JMB's plans to expand U.S. pharmaceutical manufacturing are gaining attention, with Benzinga featuring our latest progress at the Atlas Complex by CJMB in Marion, Alabama.

The newly approved blueprints for our planned $16 million IV bag manufacturing and distribution facility mark an important milestone in bringing more essential healthcare production to American soil.

With $450 million in projected annual revenue once operational, the facility is designed to combine advanced automation, robotics, and integrated distribution capabilities to support a stronger, more reliable healthcare supply chain.

Beyond manufacturing, this initiative is about building greater resilience, supporting healthcare providers, and strengthening America's ability to respond when critical medical supplies are needed most.

We're excited to see this important project featured in Benzinga!

📰 Read the full article:

Callan JMB approves blueprints for a $16 million Alabama IV plant, projecting $450 million in annual revenue to boost domestic supply chains.

10/16/2026

Building a stronger U.S. pharmaceutical supply chain starts with the right infrastructure.

At the Atlas Complex by CJMB in Marion, Alabama, Callan JMB is advancing plans to bring pharmaceutical manufacturing, quality control, warehousing, and distribution together in one location.

Through our collaboration with TRUKING TECHNOLOGY LIMITED, approximately $28 million in planned pharmaceutical manufacturing equipment will support the development of the 90,000-square-foot Marion 9 facility.

This expansion is about more than manufacturing. It’s about creating a more connected and resilient healthcare supply chain by:

- Expanding domestic production of essential pharmaceuticals

- Integrating manufacturing, quality control, storage, and distribution

- Creating new opportunities for pharmaceutical equipment distribution and assembly in North America

- Strengthening emergency preparedness and the availability of critical medicines

By building on our experience in healthcare logistics and emergency response, we're helping establish the infrastructure needed to support U.S. pharmaceutical production and long-term supply chain resilience.

Learn more about our plans for the Atlas Complex: www.globenewswire.com/news-release/2026/10/08/3377259/0/en/callan-jmb-advances-u-s-pharmaceutical-manufacturing-at-the-atlas-complex-and-expands-into-north-american-equipment-distribution-and-assembly.html

10/14/2026

Behind the scenes with Callan JMB in Texas!

Our team recently stepped in front of the camera to share insights into the strategic vision, key initiatives, and opportunities shaping the future of Callan JMB.

From advancing healthcare logistics and strengthening domestic supply chains to expanding our capabilities in manufacturing and critical infrastructure, we're focused on building the foundation for sustainable, long-term growth.

These conversations offer a closer look at the people, expertise, and strategic priorities driving our organization forward.

We're excited to share more about the work underway and what's ahead for Callan JMB.

Stay tuned!

10/13/2026

Behind every diagnostic test is a person waiting for answers.

At Callan JMB, we understand that healthcare logistics is about more than moving products. It’s about supporting timely diagnoses, informed medical decisions, and peace of mind for patients and families around the world.

We’ve helped move millions of diagnostic tests globally, supporting healthcare partners in their mission to deliver critical testing solutions where they’re needed most.

From specialized storage and inventory management to temperature monitoring and distribution, our logistics capabilities help maintain the quality, integrity, and reliability of essential healthcare products throughout the supply chain.

Every shipment represents an opportunity to make a difference. Every test has a purpose. And every successful delivery helps strengthen the connection between healthcare innovation and patient care.

We’re proud to stand behind the healthcare organizations making a global impact every day, providing the infrastructure, expertise, and dependable logistics that help them focus on what matters most: improving lives.

Learn more: www.callanjmb.com

10/08/2026

Callan JMB is advancing plans for U.S. pharmaceutical manufacturing at the Atlas Complex by CJMB in Marion, Alabama.

We have signed an initial purchase order with TRUKING and plan to invest approximately $28 million in pharmaceutical manufacturing equipment for the site, with a $500,000 down payment expected toward the initial deployment.

The collaboration also expands Callan JMB’s role beyond Atlas, with the Company positioned to serve as a North American distributor and assembly provider for TRUKING equipment.

By bringing pharmaceutical production together with Callan JMB’s existing logistics, regulatory compliance, specialty packaging, warehousing, monitoring and distribution capabilities, the Atlas Complex is being developed to support a more resilient domestic pharmaceutical supply chain.

Initial production is targeted before the end of 2027, subject to construction, equipment delivery, commissioning, validation, and applicable regulatory requirements.

Learn more: www.globenewswire.com/news-release/2026/10/08/3377259/0/en/callan-jmb-advances-u-s-pharmaceutical-manufacturing-at-the-atlas-complex-and-expands-into-north-american-equipment-distribution-and-assembly.html